10-KPeriod: FY2012

CVS HEALTH Corp Annual Report, Year Ended Dec 31, 2012

Filed February 15, 2013For Securities:CVS

Summary

CVS Health Corporation's (CVS) 2012 10-K filing reveals a robust integrated healthcare model, primarily driven by its Pharmacy Services and Retail Pharmacy segments. The company operates as the largest integrated pharmacy healthcare provider in the United States, leveraging its PBM capabilities, extensive retail store network (over 7,400 CVS/pharmacy stores), and retail clinics (MinuteClinic) to manage healthcare costs and improve patient outcomes. Financially, the company demonstrated strong revenue generation, with prescription drugs forming the largest portion of its net revenues. CVS Health's strategy emphasizes cost management through its PBM services, enhanced patient engagement programs, and convenient retail access. The company is also actively managing its capital through share repurchase programs, indicating a commitment to returning value to shareholders while continuing to invest in store development and technological advancements.

Financial Highlights

57 data points
Beta

Revenue

$123.12B

18.3% Gross Margin

Net Income

$3.86B

3.1% Net Margin

EPS (Diluted)

$3.02

Total Assets

$66.22B

Cash & Equivalents

$1.38B

Free Cash Flow

$4.64B

Financial Statements
Beta
Revenue$123.12B
Cost of Revenue$100.63B
Gross Profit$22.49B
Operating Expenses$15.28B
Operating Income$7.21B
Interest Expense$561.00M
Net Income$3.86B
EPS (Basic)$3.04
EPS (Diluted)$3.02
Shares Outstanding (Basic)1.27B
Shares Outstanding (Diluted)1.28B

Key Highlights

  • 1CVS Health is the largest integrated pharmacy healthcare provider in the U.S., operating through its Pharmacy Services (PBM), Retail Pharmacy, and Corporate segments.
  • 2The Pharmacy Services segment manages PBM services, mail order, and specialty pharmacy, serving a broad client base including employers, insurance companies, and government entities.
  • 3The Retail Pharmacy segment comprises over 7,400 CVS/pharmacy stores, offering a wide range of prescription drugs and front-store products, alongside 640 MinuteClinic locations.
  • 4Prescription drugs accounted for approximately 68.8% of net revenues in 2012, highlighting the core business strength.
  • 5The company is actively engaged in share repurchase programs, with approximately $4.7 billion available under the 2012 Repurchase Program as of December 31, 2012.
  • 6CVS Health is subject to extensive government regulation, including PBM and pharmacy operations, with significant legal proceedings detailed in the filing, particularly related to claims processing and antitrust allegations.
  • 7Significant investments in information technology are being made to enhance operational efficiency, customer service, and patient care programs.

Frequently Asked Questions

CVS Health's primary business model is that of an integrated pharmacy healthcare provider. Its competitive advantage stems from its unique position combining Pharmacy Benefit Management (PBM) services with a vast retail pharmacy network and retail clinics. This integration allows for comprehensive cost management, enhanced member engagement, and convenient access to healthcare services, aiming to improve health outcomes and reduce overall healthcare costs.

CVS Health employs several strategies to manage pharmaceutical costs. Through its PBM segment, it negotiates discounted drug acquisition costs and rebates with pharmaceutical manufacturers. It also manages formularies to promote the use of lower-cost, clinically appropriate drugs, including generics. In its retail segment, programs like 'Maintenance Choice' allow members to fill maintenance prescriptions at retail pharmacies for the same price as mail order, and various clinical services aim to improve medication adherence and manage chronic conditions, thereby reducing overall healthcare expenditure.

The key revenue driver for CVS Health is prescription drugs, which constituted approximately 68.8% of net revenues in 2012. Revenue is diversified across its Pharmacy Services (PBM) and Retail Pharmacy segments. The Retail Pharmacy segment also derives significant revenue from 'front store' products, including over-the-counter drugs, personal care, beauty, and general merchandise (approximately 31.2% of net revenues). The company aims to balance these revenue streams through integrated strategies and loyalty programs like ExtraCare.

CVS Health faces several key risks. These include efforts by payors to reduce reimbursement levels and alter healthcare financing practices, the potential loss of PBM clients or failure to win new business, risks associated with the introduction of generic drugs and new brand-name products, declining gross margins in the PBM industry, and regulatory and business changes related to Medicare Part D. Additionally, the company is exposed to risks from litigation and legal proceedings, a competitive business environment, and potential changes in industry pricing benchmarks. Compliance with a broad and complex regulatory framework is also a significant risk.